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Diethanolamine-Induced Alteration of Hepatic Mitochondrial Function and Structure. 
BARBEE, S. J., AND HARTUNG, R. (1979). Toxicol. Appl. Pharmacol. 47,431-440. Diethanol- 
amine (DEA) has been shown to interfere with phospholipid metabolism. It was hypothe- 
sized that DEA may alter membrane-bound biochemical processes which are dependent 
upon phospholipids. DEA was investigated for its effect on hepatic mitochondrial function 
and structure in the male Sprague-Dawley rat. DEA did not produce mitochondrial 
alterations in in vitro preparations from liver tissue. Similarly, acute treatment in vivo was 
without effect. However, a loss of mitochondrial integrity developed after subacute adminis- 
tration of DEA. Rats were given 0.25 (42 mg/kg/day), 1.0 (160 mg/kg/day), or 3.0 (490 mg/ 
kg/day) mg/mI in their drinking water for varying periods up to 5 weeks. The effects on 
mitochondria were dose- and time dependent. Significant alterations appeared after 3 days 
at 3.0 mg/ml and after 1 week at 1 .O mg/ml. Mitochondrial State 4 acitivity was significantly 
elevated at all three dose levels following 2 weeks of DEA treatment. Concomitantly, an 
increase was noted in the Mg2+-dependent ATPase activity from rats treated with DEA at 
2.0 mg/ml for 3 weeks. Electron micrographs indicated that treated animals had swollen 
hepatic mitochondria. The changes in the organelle may be related to alteration of phospho- 
lipid metabolism by DEA. 
Diethanolamine (DEA), a member of a class 
of compounds known as the alkanolamines, 
is used in the chemical industry as an inter- 
mediate in the production of detergents, 
solubilizers, and textile finishing agents, and 
as an absorbent for acidic gases (Sutton, 
1963). It is used in the pharmaceutical 
industry as a buffer and stabilizer for certain 
drugs (Soreat, 1973). Many biologically 
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exogenous alkanolamine compounds have 
been shown to interact with phospholipid 
metabolism (Welch and Landau, 1942; 
Wells and Remy, 1961; Chaplin and Mulford, 
1961; Chojnacki and Korzybski, 1963; 
Morin, 1969). DEA can be incorporated 
in viuo into hepatic phospholipids (Artom 
et al., 1958 ; Barbee and Hartung, 1979) and 
can inhibit the in vitro and in vivo synthesis 
of phospholipid derivatives of choline and 
ethanolamine (Barbee and Hartung, 1979). 
Choline and ethanolamine are essential in 
lipid metabolism (Fleischer and Rouser, 
1965; Fleischer et al., 1967) and membrane- 
bound enzymatic processes (Green, 1959; 
Green and Fleischer, 1963; Lenaz, 1973). 
The ability of DEA to compete with choline 
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and ethanolamine in phospholipid meta- 
bolism raises the question of whether it exerts 
an effect on membrane-bound enzymatic 
processes. Foster (1971) noted that repeated 
oral administration of DEA reduced the 
activity of hepatic microsomal drug-meta- 
bolizing enzymes from the rat. This informa- 
tion suggests that DEA may exert an effect on 
other membrane-bound cellular processes. 
The purpose of this study was to investigate 
whether DEA alters the function and struc- 
ture of the mitochondrion from hepatic 
tissue of the rat. This organelle was chosen 
for study because it is dependent upon 
phospholipids for proper function (Green 
and Fleischer, 1963) and it is intimately 
involved in cell metabolism (Chance and 
Hollunger, 1961; Chance, 1961). 
METHODS 
Male albino rats of the Sprague-Dawley strain 
were used throughout this investigation at an initial 
weight of 150-200 g. They were maintained in air- 
conditioned quarters and supplied with food and 
water ad /i&ram. All animals were allowed to accli- 
mate for at least 3 days before they were used in 
experimentation. Sacrifice was accomplished by 
exsanguination via open chest heart puncture after the 
animal was anesthetized with ether. 
Diethanolamine (DEA) was purchased from the 
J. T. Baker Chemical Company, and it was used 
without further purification. 
DEA was obtained as the free base, and as such was 
not suitable for direct administration because of its 
high pH in water. A desired amount of DEA was 
placed in a beaker with an equal volume of water. 
The beaker was placed in a water ice bath and 
neutralized to pH 7.4 with HCI. Throughout the 
neutralization process, the temperature was kept 
below 30°C to minimize alteration of the compound. 
The in vitro and acute in riuo effect of DEA on 
hepatic mitochondria was assayed at 5 mM and 
490 mg/kg, respectively. To assess the subacute 
in viuo effect of this substance on hepatic mitochon- 
drial function DEA was administered in the drinking 
water according to the following dosing regimen: 
0.25 mg/ml (42 mg/kg/day) for 2 and 5 weeks, 
I.0 mg/ml (160 mg/kg/day) for I, 3, and 5 weeks, and 
3.0 mg/ml (490 mg/kg/day) for I day, 3 days, and 
1, 2, 3, and 5 weeks. Water consumption was moni- 
tored to approximate the dose consumed in mg/kg/ 
day. The dosages were calculated in terms of the free 
base. 
Hepatic mitochondria were isolated according to 
the method of Brabec et al. (1974). The respiratory 
rate, acceptor control ratio, and ADPi for hepatic 
mitochondria were determined using a Model 53 
oxygen electrode system from Yellow Springs Instru- 
ment Company as described by Estabrook (1967) in 
0.15 M sucrose, 20 mM potassium chloride, 20 mM 
Tris (pH 7.0 at 30°C) IO mM potassium phosphate 
(monobasic), 5 mM magnesium chloride, and 100 mM 
succinate from the method of Brabec e/ al. (1974). 
The medium was added in a volume of 2.4 ml 
combined with 0.1 ml of succinate. The succinate 
was prepared by placing the desired amount in a 
volumetric container and adjusting the pH to 7.0 with 
potassium hydroxide. The system was maintained at 
30°C in a circulating water bath. The oxygen elec- 
trode was set in place and the system was allowed to 
equilibrate at 100% of oxygen saturation. The 
nanomoles of oxygen contained in the medium were 
calculated based on volume and temperature (Strick- 
land and Parsons, 1968). The assay was initiated by 
the addition of 50~1 of mitochrondrial suspension 
and 200 nmol ADP. The ADP causes an immediate 
increase in the rate of oxygen utilization; this rate 
(State 3) is maintained until the added ADP is 
phosphorylated. At this time, ADP becomes limiting 
and the rate of oxgyen consumption decreases 
(State 4). State 3 and State 4 activity may be deter- 
mined by calculating the nanomoles of oxygen 
consumed per minute and relating this to milligrams 
of mitochrondrial protein added. The acceptor 
control ratio is determined by dividing State 3 
activity by that of State 4. The ADPjO ratio is calcu- 
lated by dividing the nanomoles of ADP phospho- 
rylated by nanoatoms of oxygen consumed during 
each interval at State 3. 
The study to assess the subacute effects of DEA on 
hepatic mitochondrial membrane permeability was 
divided into two parts, evaluating the inner and outer 
mitochondrial membranes. The method and duration 
of administration and dose of DEA were kept con- 
stant for both investigations. Each experimental and 
control group consisted of four animals each. The 
experimental group was given 3.0 mg/ml DEA in 
their drinking water for 2 weeks. 
Outer mitochondrial membrane permeability was 
assayed according to a modification of the method of 
Wattiaux-DeConnick and Wattiaux (1971) by follow- 
ing the spectrophotometric reduction of cytochrome c 
by sulfite-cytochrome c reductase at 550 nm. Mito- 
chrondria were prepared as previously described. 
The reagents consisted of a buffer, prepared by 
placing 1.0 ml of 0.2 M Tris and 0.1 mM EDTA 
(pH 8.5) in 9 ml of isolation medium, 0.01 M sodium 
sulfite, 0.25 mM cytochrome c, 13.5 mM potassium 
cynaide, buffered to pH 8.0 with the Tris-EDTA 
solution described above, and mitochondria diluted 
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1: 10 with 0.25 M sucrose just prior to assay to 
achieve 2-3 mg protein/ml. Two milliliters of buffer, 
0.1 ml potassium cyanide, 0.1 ml sodium sulfite, and 
50.~1 of mitochondrial suspension were introduced 
into 3-ml cuvettes. In order to establish a recorded 
baseline, the system was allowed to equlibrate 
4 min before addition of substrate. The reaction was 
started by adding 0.2 ml cytochrome c. The progress 
of the reaction was monitored for approximately 
20min at 30°C in a Gilford recording spectrophoto- 
meter. 
Cytochrome c does not freely permeate the outer 
membrane. However, when the outer membrane is 
sufficiently altered by detergents or toxic substances, 
the cytochrome c is free to migrate through the 
membrane where it is reduced, ,then back out into the 
medium where it is measured. Potassium cyanide is 
added to the medium to prevent the reoxidation of 
cytochrome c by cytochrome oxidase. The activity of 
sulfite-cytochrome c reductase is expressed as 
AOD/min/mg protein. 
The permeability of the inner membrane was 
determined following the method of Byard et al. 
(1975). Mitochondria were isolated and assayed for 
oxygen consumption as previously described using 
NADH instead of succinate as the substrate. The 
results were expressed as the difference in respiration 
between an excess of NADH and ADP compared to 
no added NADH and an excess of ADP with units 
given as nmol O,/min/mg protein. According to 
Van den Bergh and Slater (1962), extramitochondrial 
NADH itself cannot penetrate the mitochondrial 
membrane. If  the mitochondria are sufficiently 
damaged, NADH can enter the inner compartment 
and be oxidized at the expense of oxygen. 
Mitochondrial ATPase was measured following 
the method of Pederson and Morris (1974). Treated 
animals received 3.0 mg/ml DEA in their drinking 
water for 3 weeks. 
Hepatic tissue was taken for ultrastructural 
examination as described by Sibrack er a/. (1974). 
Animals in the treated group received drinking water 
containing 3.0 mg/ml DEA for 2 weeks. 
Protein concentration was determined by the 
method of Lowry et al. (1951). 
Statistical significance of the data was determined 
by analysis of variance and Student’s I test. 
RESULTS 
DEA was ineffective in producing hepatic 
mitochondrial alteration in vitro; and simi- 
larly, acute in clillo treatment for 24 hr was 
without effect. These data are presented in 
Table 1. 
When DEA was administered subacutely, it 
produced significant alteration of hepatic 
mitochondrial integrity. No significant effect 
was observed in renal mitochondria exposed 
in vitro and in vivo to DEA. 
The results of the subacute effect of DEA 
TABLE I 
LACK OF EFFECT OF in Vitro AND ACUTE in Vioo EXPOSURE OF DEA 
ON HEPATIC MITOCHONDRIA” 
Mitochondrial variable 
Treatment Acceptor 
State 3 State 4 control 
activity* activity* ratio’ ADP/O” 
Control 134.9f 1.9 25.2kO.S 5.37kO.03 I .46 k 0.02 
In vitro 140.4f2.2 25.9kO.6 5.42kO.04 1.45+0.01 
In civo 135.8k3.0 25.7kO.7 5.29+0.03 1.45 + 0.02 
a Animals administered the acute dose received 3 mg/ml (490 mg/kg/ 
day) DEA in their drinking water for 24 hr. The in vifro effect was 
determined by isolating control mitochondria and assaying them in the 
presence of 5 mM DEA. Each value represents the mean+SE of data 
from at least four animals. 
b Expressed as nmol OJmg protein/min. 
c Expressed as the ratio of State 3/State 4. 
d Expressed as the ratio of nmol ADP phosphorylated to natoms 0, 
consumed during State 3 respiration. 
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on hepatic mitochondrial State 4 activity and the duration of administration. DEA given at 
acceptor control ratio are presented in Fig. 1. 1.0 mg/ml for 1 week produces no increase 
The data indicate a continued increase in compared to controls, whereas 3.0 mg/ml for 
State 4 for up to 3 weeks of DEA adminis- the same time produces a 9 % increase. When 
tration, after which it remains at more or less 1.0 mg/ml is given for 3 weeks, a 45 % in- 
constant levels compared to those attained crease is seen. The dose at 0.25 mg/ml 
after 3 weeks of dosing. The increases in increases State 4 activity to only 12% above 
State 4 are dependent both on the dose and controls after 2 weeks, and this level is main- 
40 
I I I I I I 
1 2 3 4 5 
TIME OF ADMINISTRATION (WEEKSI 
FIG. 1. The upper figure represents hepatic mitochondrial State 4 activity after subacute oral ad- 
ministration of DEA. The lower figure represents hepatic mitochondrial acceptor control ratio 
after subacute oral administration of DEA. DEA was administered orally in drinking water at 
0.25 mg/ml (42 mg/kg/day) O----O, 1 .O mg/ml (160 mg/kg/day) W-B, and 3.0 mg/ml (490 mg/ 
kg/day) A-A. Each point represents the mean+ SE of data from at least four animals. A plus sign 
(+) indicates values which are statistically significant (p < 0.05). 
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tained throughout 5 weeks of administration. 
Significant differences were obtained for all 
values except after 1.0 mg/ml DEA for 
1 week. 
The decline in the acceptor control ratio 
(ACR) in hepatic mitochondria is the result 
of an increase in State 4 since no change was 
observed in State 3 activity. As with State 4 
activity, the effect on the ACR is dose and 
time dependent. The only dose which did not 
show a significant difference from control 
values is that at 0.25 mg/ml. The ACR calcu- 
lated for animals receiving 1 .O and 3.0 mg/ml 
declined to 75 % of control after 2 and 3 weeks 
of administration. This value is maintained 
for both dose levels through 5 weeks of 
testing. 
To provide an explanation for the increase 
in State 4, Mg*+-dependent ATPase was 
determined in animals given 3.0 mg/ml DEA 
for 2 weeks (Table 2). A significant increase 
in the activity of this enzyme occurred. The 
rise was comparable to that observed for 
State 4 activity. Since State 4 activity is 
defined as respiration in the absence of ADP, 
any endogenous process providing a source 
of ADP would stimulate electron transport, 
and hence oxygen consumption by mito- 
chondria. 
The ADP/O ratio did not exhibit significant 
differences at any time or dose level. This 
may appear anomalous, but two factors must 
be considered in connection with these 
TABLE 2 
COMPARISON OF Mg*+-DEPENDENT ATPase ACTIVITY 
IN HEPATK MITOCHONDRIA ISOLATED FROM CONTROL 
AND DEA-TREATED ANIMALS’ 
Animal group ATPase activityb 
Control 42.3+4.1 
DEA treated 69.7+4.8’ 
’ Each value represents the mean f  SE of data from 
four animals. Treated animals were given 3.0 mg/ml. 
(490 mg/kg/day) DEA via the drinking water for 2 
weeks. 
b Expressed as nmol P, released/mg protein/min. 
c p <0.05. 
findings. First, ADP/O ratios are deter- 
mined when the mitochondrion is in State 3 
respiration, and very little change was 
observed from controls during this phase of 
respiration. Second, mitochondria which are 
tightly coupled always have high ADP/O 
ratios, and mitochondria which are loosely 
coupled may or may not have low ADPjO 
ratios. It is of interest that the acceptor 
control ratio is more indicative of mito- 
chondrial integrity than is the ADPjO ratio 
(Chance and Williams, 1955). 
The permeability of the mitochondrial 
membranes was determined to try to explain 
partially the increase in State 4 activity. 
Although experimental animals treated with 
3.0 mg/ml DEA for 2 weeks showed no 
evidence of differences in permeability from 
controls, the possibility still exists that DEA 
treatment could result in alterations in 
permeability. The evaluation of inner and 
outer membrane permeability, in this study, 
is based on the passage of relatively large 
molecules through the membrane, NADH 
and cytochrome c with molecular weights of 
709 and 12,270, respectively. A point to 
remember regarding NADH is that it is 
actively excluded from mitochondria, thus 
the cytoplasmic and intramitochondrial 
pools of this molecule are effectively segre- 
gated (Van den Bergh and Slater, 1962). 
These substances are considerably larger than 
ions, whose entry into the cell and its organ- 
elles also is selectively controlled. The possi- 
bility cannot be overlooked that DEA-treated 
mitochondria possess altered permeability 
toward small ions without any observable 
change in the permeability to much larger 
molecules. Data consistent with this state- 
ment are illustrated in Fig. 2. These ‘are 
transmission electron micrographs of sections 
from hepatic tissue. Figure 2a represents 
untreated tissue, while Fig. 2b illustrates a 
section from an animal treated with 3.0 mg/ 
ml DEA for 2 weeks. The mitochondria 
from DEA-treated animals are consistently 
spherical, and also appear larger than 
mitochondria from control animals. 
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FIG. 2. Transmisslon electron micrographs of hepatic tissue from the rat. (a) Tissue from a control 
animal; (b) tissue from a rat fed diethanolamine at a concentration of 3 mg/ml in drinking water for 
2 weeks. The following structures may be identified: mitochondria (M), endoplasmic reticulum (ER), 
cell nucleus (N). and glycogen deposits (Cl). (a) x 15, 750; (b) x 16,500. 
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DISCUSSION 
Repeated administration of DEA to rats 
produces alteration of function in hepatic 
mitochondria. No observable change is noted 
in this organelle upon in vitro and acute 
in ciao exposure to DEA. The functional 
alteration seen in hepatic mitochondria is due 
to an increase in State 4 activity caused in 
part, if not completely, by elevation in the 
Mg2+-dependent ATPase activity. 
The ATPase activity in mitochondria is 
normally low, but it is greatly stimulated by 
in vitro treatment with agents that alter 
membrane permeability (Mitchell, 1961). 
Interestingly, DEA exerts no effect on State 4 
activity in vitro. Barbee and Hartung (1979) 
noted that subacute administration of DEA 
inhibits the in dvo synthesis of phospho- 
glycerides of choline and ethanolamine. 
These investigators also found that DEA 
can serve as a substrate in phospholipid 
metabolism in vitro, and confirmed that it can 
be incorporated into hepatic phospholipids 
in riro. The interaction of DEA in phospho- 
lipid metabolism may result in the incorpora- 
tion of DEA into mitochondrial membrane 
structure as a phospholipid derivative. 
Since mitochondrial function is highly 
dependent upon phopholipids, any altera- 
tion in phospholipid metabolism could 
easily result in functional change in this 
organelle. Atypical constituents may produce 
alterations in the membrane, thereby in- 
creasing mitochondrial membrane permea- 
bility. Even though no change was observed 
in permeability to cytochrome c and NADH, 
the possibility still exists that alterations have 
occurred to allow lower molecular-weight 
substances easier access through the mito- 
chondrial membrane, e.g., hydrogen ion 
(H+) and alkali metal ions. 
Lipids are impermeable to protons and 
thereby act as an insulator to inhibit H+ 
transport (Scarpa and DeGier, 197 1). Cereijo- 
Santalo (I 967) noted that intact mitochondria 
are impermeable to H+ and he concluded 
that the latency of ATPase activity is due to 
accumulation of H’ ions in the membrane 
during that portion of respiration in which 
ATP is not being actively synthesized (State 
4). The removal of these protons due to 
increased permeability or by exchange with 
other cations may act to unmask the latent 
ATPase and thus increase State 4 activity. 
Influx of alkali-metal ions can increase 
ATPase activity when the mitochondrial 
membrane is made more permeable to these 
ions through treatment with the detergent 
Triton X-100 (Cereijo-Santalo, 1968). The 
membrane appears to be susceptible to 
differential structural alteration, since the 
author found that as the detergent concen- 
tration rose, the alkali-metal ions became 
increasingly more permeable in the following 
order: Lii-, Na+, K+, Rb+, Cs+. This sequence, 
in order of their decreasing hydrated ionic 
radii, may indicate the formation of flaws or 
pores in the membrane which increase in 
diameter with increasing concentration of 
detergent. Atypical membrane constituents 
may produce similar flaws or pores thereby 
altering the permeability to selected elemental 
ions. 
Cockrell et al. (1966) found that mito- 
chondria in a medium of K+, Mgz+, Pi, and 
an oxidizable substrate exhibited a stimula- 
tion of oxygen uptake and swelling when 
made more permeable to KC. They attribute 
the swelling to permeable anions which 
accompany the cations. Chappell and Crofts 
(1965) found that the influx of K t ions into 
mitochondria was followed by H + ejection in 
order to maintain ion balance, and mito- 
chondrial swelling due to Pi entry. It is pos- 
sible that small increases in the permeability 
of the mitochondrial membrane toward 
certain cations will produce swelling and 
elevations in oxygen consumption without 
affecting the ability to synthesize ATP. This 
may offer an explanation for the swollen 
appearance of hepatic mitochondria from 
rats treated with DEA. 
It is not possible, at this time, to define the 
mechanism by which DEA produces altera- 
tion of hepatic mitochondrial function and 
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structure, although it presumably is related to 
the involvement of DEA with phospholipid 
metabolism. DEA does undergo incorpora- 
tion to a phospholipid derivative in vivo, and, 
as such, is probably incorporated into mito- 
chondrial membrane structure. It is tempting 
to speculate that prolonged exposure to DEA 
could alter lipid environments of other 
hepatic cellular constituents, or perhaps in 
other tissues, creating changes in other 
physiologic processes. 
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